跳至主要内容
临床试验/NCT07729280
NCT07729280尚未招募不适用

The Effect of Preoperative Oral Carbohydrate Loading on Insulin Resistance in Pediatric Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial

Rifdhani Fakhrudin Nur1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2026年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
44
试验地点
1
主要终点
HOMA-IR (Homeostasis Model Assessment for Insulin Resistance)

研究概览

简要总结

Surgical stress and preoperative fasting can induce insulin resistance, characterized by impaired cellular response to insulin and resulting hyperglycemia. In pediatric patients undergoing cardiac surgery, this metabolic stress response may negatively affect postoperative recovery. Although preoperative oral carbohydrate loading, defined as administering a carbohydrate-rich beverage before surgery rather than prolonged fasting, has demonstrated efficacy in reducing postoperative insulin resistance in adults, evidence supporting its use in pediatric cardiac surgery remains limited.

This randomized controlled trial aims to determine whether preoperative oral carbohydrate loading reduces perioperative insulin resistance, as measured by the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), in pediatric patients undergoing cardiac surgery. The study will compare outcomes between children who receive an oral carbohydrate beverage prior to surgery and those who follow standard preoperative fasting protocols.

详细描述

This study is a prospective, single-blind, randomized controlled trial of pediatric patients who underwent elective cardiac surgery at Dr. Sardjito General Hospital, Yogyakarta, Indonesia, from April to August 2026. The study sample consisted of pediatric patients aged 2-16 years with an ASA physical status of 2 or 3 who had good tolerance for enteral fluid administration. Patients will be randomly assigned to one of two groups: 1. Intervention Group (Carbohydrate Loading): 3 mL/kg body weight of a maltodextrin-based carbohydrate drink 2 hours before anesthesia; 2. Control Group (Placebo Loading): 3 mL/kg body weight of plain water 2 hours before anesthesia. All patients will follow standard preoperative fasting guidelines. Blood samples for glucose and insulin testing will be collected immediately after induction (baseline), at 0 hours of Intensive Care Unit (ICU) admission, and at 24 hours of ICU admission. The primary outcome is the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). Secondary outcomes include blood glucose levels, serum insulin concentration, exogenous insulin dose, and glycemic variability.

All study participants will undergo preoperative assessment, followed by a carbohydrate-loading protocol, and assessment of blood glucose levels, insulin resistance, exogenous insulin administration, and intraoperative and postoperative glycemic variability. Numerical data will be presented as means and standard deviations. Categorical data will be presented as counts and percentages. The Shapiro-Wilk normality test will be applied to all numerical data. Subject characteristics between the two groups will be compared using the Chi-square test for categorical data and the t-test (for normally distributed data) or the Mann-Whitney test (for non-normally distributed data) for numerical data. Pre- and postoperative HOMA-IR values will be compared using a paired t-test if the data are normally distributed, or a two-way ANCOVA (univariate GLM) if they are not. A p-value < 0.05 will be considered statistically significant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
2 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 2-16 years.
  • ASA physical status 2 or 3
  • Good tolerance of enteral feeding

排除标准

  • History of type 1 diabetes mellitus.
  • History of thyroid insufficiency treated with thyroid medication.
  • History of adrenal insufficiency treated with corticosteroids.
  • History of gastroesophageal reflux disease.
  • Patients receiving preoperative parenteral nutrition.
  • Emergency or urgent cardiac surgery.

结局指标

主要结局

HOMA-IR (Homeostasis Model Assessment for Insulin Resistance)

时间窗: Baseline, 0 Hour ICU Admission, 24 hours ICU Admission

The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) is calculated as fasting insulin (µU/mL) × fasting glucose (mmol/L) / 22.5. Higher values indicate greater insulin resistance.

次要结局

  • Blood Glucose Level(Baseline, 0 hour ICU Admission, 24 hours ICU Admission)
  • Serum Insulin Concentration(Baseline, 0 hour ICU Admission, 24 hours ICU Admission)
  • Exogenous Insulin Dose(Baseline, 0 hour ICU Admission, 24 hours ICU Admission)
  • Glycemic Variability(Baseline, 0 Hour ICU Admission, 24 Hours ICU Admission)

研究者

发起方
Rifdhani Fakhrudin Nur
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Rifdhani Fakhrudin Nur

Principal Investigator

Gadjah Mada University

研究点 (1)

Loading locations...

相似试验